Within India’s Multi-Site Trials, Tier 2 Cities Are Now Ahead
India’s clinical research landscape continues to evolve, driven by changing therapeutic priorities, broader geographic participation, and sustained investment from both domestic and global sponsors. The January to June 2026 edition of IndiaTrialPulse by StriderDCT brings together six months of clinical